XML 35 R24.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY (Tables)
6 Months Ended
Jun. 27, 2026
EQUITY  
Schedule of RSUs activity

Weighted average grant

Number of RSUs

date fair value per share

  ​ ​ ​

In thousands

  ​ ​ ​

U.S. dollars

Outstanding as of December 27, 2025

32,853

$

20

Granted

8,356

8

Vested

(1,450)

19

Forfeited

(1,535)

18

Outstanding as of June 27, 2026

38,224

$

17

  ​ ​ ​

  ​ ​ ​

Weighted average grant

Number of RSUs

date fair value per share

In thousands

U.S. dollars

Outstanding as of March 28, 2026

 

37,100

$

18

Granted

 

2,906

7

Vested

 

(1,054)

17

Forfeited

 

(728)

15

Outstanding as of June 27, 2026

 

38,224

$

17

Schedule of restricted shares activity

  ​ ​ ​

Number of Restricted

  ​ ​ ​

Grant date fair value per

Shares

share

In thousands

 

 U.S. dollars 

Outstanding as of December 27, 2025

 

$

Granted

23,652

 

9

Outstanding as of June 27, 2026

23,652

 

$

9

  ​ ​ ​

Number of Restricted 

  ​ ​ ​

Grant date fair value per

Shares

share

In thousands

U.S. dollars

Outstanding as of March 28, 2026

 

23,652

$

9

Outstanding as of June 27, 2026

 

23,652

$

9

Schedule of share-based compensation expenses

Three Months Ended

Six Months Ended

U.S. dollars in millions

  ​ ​ ​

June 27, 2026

  ​ ​ ​

June 28, 2025

  ​ ​ ​

June 27, 2026

  ​ ​ ​

June 28, 2025

Cost of revenue

$

1

$

1

$

1

$

1

Research and development, net (1)

67

59

135

116

Sales and marketing

1

2

3

3

General and administrative

19

7

33

14

Total share-based compensation

$

88

$

69

$

172

$

134

(1)Not including R&D Law incentive grant related to ordinary income from sold RSUs as further detailed in Note 2 under Research and Development Incentives, which depends on the actual sale of the shares of common stock issued upon the conversion of RSUs.